Here are four things to know.
- Dr. Gottlieb said President Trump’s federal hiring freeze no longer applies to the FDA.
- The FDA head responded to criticism surrounding the proposed budget, saying he was not involved with developing the budget proposal, according to the report.
- Dr. Gottlieb said he will soon share a “drug competition action plan” and a list of off-patent drugs with no current generic competition.
- He also said the FDA plans to update its risk evaluation and mitigation strategy regulations — which ensure the benefits of a drug or biologic outweigh its risks — to prevent drugmakers from taking advantage of the rules for their own benefit, reports Regulatory Focus.
More articles on supply chain:
Supply chain tip of the day: Schedule daily huddles with surgical teams
Controversial bill addressing diabetes drug prices reaches Nevada governor’s desk: 5 things to know
Marijuana-derived epilepsy drug nears FDA approval
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
